Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • M4TTN
    Member
    • Jan 2014
    • 77

    #1

    Second hand HiSeq2500 - queries

    Hi there, has anyone experienced transfer of ownership of an Illumina sequencer?

    Will these work without an active service contract?

    We have been offered a HiSeq2500 at a very low price (free..), but don't do a great deal of sequencing, 1-2 runs per month externally on a NextSeq500 and 1-2 runs per month internally on a MiSeq. We are wondering if the rapid run mode of the HiSeq2500 might make sense. Similar output to NextSeq, and much cheaper costing (even cheaper than MiSeq), but HiSeq2500 service contract would be prohibitive for us. Thanks!
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    If you only plan to do one or two runs a month it may not be worth your time. Sequencers have fine capillaries, complex electronics and are generally happier when run reasonably continuously. The machine will run for a time but you are going to inevitably need service on it at some point and then things will get rather expensive fast, without a service contract.

    Illumina is actively trying to wean people off older HiSeq. Even though reagents are supposed to remain available for another 2-4 years, their price has been going up steadily. So the rapid runs you find attractive now will likely cost more every passing year.

    That said, since the price is right (free) and if you are willing to gamble away some of your time/effort, you will be able to get some sequencing out of the machine.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-13-2026, 09:56 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Working...